Life Sciences Strategy: Senior Team

Life Sciences Strategy: Senior Team

Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357
Dr. Bell frequently testifies as an expert witness on damages in intellectual property, finance, and antitrust litigation in courts and arbitration proceedings in North America, Europe, Asia, and Australia. Dr. Bell’s business consulting engagements focus on the economics of business strategy, working with firms to develop sustainable competitive... Read more
Vice President
Boston
+1-617-425-3184
Mr. Jeffrey S. Aroy is an experienced consultant, seasoned senior executive, and strong strategic thinker with more than 20 years in the industry. His consulting experience focuses on corporate and product strategy, companion diagnostics, strategic marketing, emerging markets, and M&A-oriented growth. Mr. Aroy has helped life sciences... Read more
Vice President
Summit
+1-404-431-1306
Robert Broadnax has more than 17 years of pharma/biotech commercialization, sales, and advanced analytics experience ranging from early pipeline to in-line brands with expertise in specialty disease areas, including Oncology, Immunology and Virology. Mr. Broadnax has developed and executed global and regional go to market strategies, launched new... Read more
Vice President
Boston
+1-617-425-3000
Mr. Brubacher has 25 years of pharmaceutical and biotech commercialization experience and has led cross-functional marketing and commercial teams during the development and launch of pharmaceutical products.  His expertise includes global commercial planning and market strategy, analytics, market simulation, rare diseases, lifecycle management,... Read more
Vice President
London
+44-20-7664-3716
Andrew Butcher is a vice president in the Life Sciences Practice of Charles River Associates. An expert in communications and reputation management, he advises leadership and brand teams on how to maximize the impact of stakeholder relations and communications to drive business strategy and internal change. He consults with life sciences firms on... Read more
Vice President
Lucerne
+41-412278060
Angela De Martini is a vice president in CRA’s Life Sciences Practice, specializing in pharmaceuticals and medical devices. Angela serves clients across a wide range of functions, including commercial, operations, medical affairs, market access, and public affairs. Prior to CRA’s acquisition of C1 Consulting in 2017, she was a director at C1... Read more
Vice President
Munich
+49 89 20 18 36 36-7
Justus Dehnen is a vice president in the Life Sciences Practice with more than 15 years in the industry. His consulting experience focuses on pricing and market access, contracting and loss of exclusivity (LoE) strategy development projects for national and international Life Science companies. He works across multiple therapeutic areas for pharma... Read more
Vice President
Boston
+1-617-425-3083
Mr. Lev Gerlovin has more than 15 years of consulting experience across strategic planning, litigation, and policy spheres. His recent focus has been in leading strategy and litigation engagements for a diverse set of clients, including leading pharmaceutical and biotechnology manufacturers, distributors, health plan providers, and industry groups... Read more
Vice President
Boston
+1-617-425-3326
Mr. Rhett Johnson has more than 14 years of consulting experience, and he specializes in developing therapeutic area, market access, and growth strategies for clients in the life sciences industry. His extensive strategy consulting experience includes pricing, managed markets, global market access, product and portfolio positioning, competitor... Read more
Vice President
Boston
+1-617-270-3311
Ned Kitfield has extensive experience providing commercial decision support for large and small biotech, pharmaceutical, and healthcare companies.  While Ned has worked across a broad spectrum of therapeutic categories, he brings particular insight into rare and ultra-orphan diseases.  He expertise includes everything from commercialization... Read more
Vice President
New York
+1-212-520-7260
Mr. Matthew Majewski has a track record of providing life science clients with analytically based solutions to their strategic issues. He has led a range of strategy engagements from product related topics to corporate challenges. Prior to joining CRA, Mr. Majewski was a consultant at Stratēgyx where he developed managed market strategies for pre-... Read more
Vice President
Summit
+1-212-520-7159
Aileen Nicoletti is a vice president in the Life Sciences Practice at CRA. She has expertise in market research, new product planning, business development, and strategic planning. Dr. Nicoletti focuses on therapeutic area growth and portfolio management strategy for clinical stage pharmaceutical and biotech products. She has an understanding of... Read more
Vice President
Boston
+1-617-425-6509
Andrew Parece is a vice president in the Life Sciences Practice. With more than 30 years of consulting experience, Mr. Parece specializes in pricing and competitive strategy, quantitative analysis, modeling, and market research, primarily in the pharmaceutical, biotech, and life sciences industries. His work in pharmaceuticals has focused on... Read more
Vice President
Boston
+1-617-425-3093
Prior to joining CRA in 1995, Mr. Persampieri held management consulting positions at Arthur D. Little and A.T. Kearney, where he was responsible for client development, sales, and management of consulting assignments related to product/market strategy development and business process reengineering. Education M.S. Engineering (Materials Science),... Read more
Vice President
Lucerne, San Francisco
+1-415-490-2730; 41-79-750-02-06
Elizabeth Rountree has 20+ years of customer insights experience (data analytics, primary market research) in biopharmaceuticals as well as in-depth expertise in neuroscience and oncology. Prior to joining CRA, she was a co-founder of three life sciences consulting and market research firms: C1 Consulting, Cozint, and HIV Research. Education MBA,... Read more
Vice President
Summit
+1-609-335-2681
Rob Sederman has 25+ years of data analytics and consulting expertise in pharma/biotech. Prior to joining CRA, he was a co-founder of C1 Consulting and led their effort to develop an Advanced Analytics practice area. Mr. Sederman has held executive positions at ZS Associates and NOP World Health. Education MBA, Harvard Business School BS,... Read more
Senior Consultant to CRA
New York
+1-212-520-7195
James Swayzee is an independent consultant to several life sciences companies in the US and Europe. His current clients are biopharma start-ups in the areas of oncology, neurology, infectious disease, and vascular disease who seek his advice on strategies for corporate and clinical development as well as interactions with industry. Until his 2007... Read more
Vice President
San Francisco
+1-510-595-2897
Ryan Tubman is a vice president in the Life Sciences Practice at CRA. His work focuses on leveraging analytics and customer insights to develop evidence-based strategies for pharmaceutical and biotech organizations. This work spans early pipeline to in-line products, often involving patient-level claims, data-based analytics and modelling, market... Read more
Principal
Boston
+1-617-425-3055
Stephanie Andrews consults with corporations in the metals and materials industries on market and competitive analysis, operations management, and international competition. She has worked on many large-scale engagements, including a market development and strategy assessment for a major international specialty metals producer, and analysis of... Read more
Principal
Boston
+1-617-425-3035
Ms. Becky Davis is a principal in the Life Sciences Practice of CRA. She has more than 15 years of consulting experience with CRA and provides strategic consulting services to clients in a number of industries. Ms. Davis has significant expertise in life sciences, metals/mining, aerospace materials, and manufactured parts. She has extensive... Read more
Principal
New York
+1-212-520-7121
Joanna Lee's consulting experience includes advising pharmaceutical, biotech, and medical device organizations as well as financial institutions. She consults on portfolio strategy, market entry strategy, product launch, life cycle management, global market access and reimbursement, and due diligence across a diverse set of therapeutic areas for... Read more